title: Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake.
abstract: Glucocorticoids increase adipocyte proliferation and differentiation, a process underpinned by the local reactivation of inactive cortisone to active cortisol within adipocytes catalyzed by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). The adrenal sex steroid precursor dehydroepiandrosterone (DHEA) has been shown to inhibit 11β-HSD1 in murine adipocytes; however, rodent adrenals do not produce DHEA physiologically. Here, we aimed to determine the effects and underlying mechanisms of the potential antiglucocorticoid action of DHEA and its sulfate ester DHEAS in human preadipocytes. Utilizing a human subcutaneous preadipocyte cell line, Chub-S7, we examined the metabolism and effects of DHEA in human adipocytes, including adipocyte proliferation, differentiation, 11β-HSD1 expression, and activity and glucose uptake. DHEA, but not DHEAS, significantly inhibited preadipocyte proliferation via cell cycle arrest in the G1 phase independent of sex steroid and glucocorticoid receptor activation. 11β-HSD1 oxoreductase activity in differentiated adipocytes was inhibited by DHEA. DHEA coincubated with cortisone significantly inhibited preadipocyte differentiation, which was assessed by the expression of markers of early (LPL) and terminal (G3PDH) adipocyte differentiation. Coincubation with cortisol, negating the requirement for 11β-HSD1 oxoreductase activity, diminished the inhibitory effect of DHEA. Further consistent with glucocorticoid-opposing effects of DHEA, insulin-independent glucose uptake was significantly enhanced by DHEA treatment. DHEA increases basal glucose uptake and inhibits human preadipocyte proliferation and differentiation, thereby exerting an antiglucocorticoid action. DHEA inhibition of the amplification of glucocorticoid action mediated by 11β-HSD1 contributes to the inhibitory effect of DHEA on human preadipocyte differentiation.
authors.affiliation: Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom.
authors.forename: Joanne C
authors.initials: JC
authors.lastname: McNelis
authors.forename: Konstantinos N
authors.initials: KN
authors.lastname: Manolopoulos
authors.forename: Laura L
authors.initials: LL
authors.lastname: Gathercole
authors.forename: Iwona J
authors.initials: IJ
authors.lastname: Bujalska
authors.forename: Paul M
authors.initials: PM
authors.lastname: Stewart
authors.forename: Jeremy W
authors.initials: JW
authors.lastname: Tomlinson
authors.forename: Wiebke
authors.initials: W
authors.lastname: Arlt
mesh_terms: D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1 / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics; D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism; D050156:Adipogenesis / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D003124:Colorimetry; D017931:DNA Primers; D003687:Dehydroepiandrosterone / Q000378:metabolism / Q000494:pharmacology*; D005938:Glucocorticoids / Q000037:antagonists & inhibitors*; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D013936:Thymidine / Q000378:metabolism
chemical_list: D017931:DNA Primers; D005938:Glucocorticoids; D012333:RNA, Messenger; D003687:Dehydroepiandrosterone; D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1; D005947:Glucose; D013936:Thymidine
keywords: 11β-hydroxysteroid dehydrogenase type 1; dehydroepiandrosterone; human adipogenesis; insulin sensitivity
references.citation: Diabetes. 1998 Jan;47(1):138-41
references.pmid: 9421389
references.citation: Horm Metab Res. 2002 Nov-Dec;34(11-12):752-7
references.pmid: 12660894
references.citation: IUBMB Life. 2002 Dec;54(6):365-70
references.pmid: 12665248
references.citation: Steroids. 2004 Apr;69(4):279-89
references.pmid: 15183694
references.citation: Biochem Biophys Res Commun. 1998 Jul 30;248(3):497-504
references.pmid: 9703954
references.citation: Prog Clin Biol Res. 1988;265:161-75
references.pmid: 2970093
references.citation: Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):377-85
references.pmid: 16101547
references.citation: Steroids. 2006 Aug;71(8):674-82
references.pmid: 16762384
references.citation: JAMA. 2004 Nov 10;292(18):2243-8
references.pmid: 15536111
references.citation: J Biol Chem. 1994 Jan 28;269(4):2516-20
references.pmid: 8300578
references.citation: J Mol Endocrinol. 2005 Jun;34(3):675-84
references.pmid: 15956339
references.citation: Mol Pharmacol. 2003 Mar;63(3):722-31
references.pmid: 12606783
references.citation: J Clin Endocrinol Metab. 1987 Apr;64(4):832-5
references.pmid: 3546356
references.citation: Endocr Rev. 2004 Oct;25(5):831-66
references.pmid: 15466942
references.citation: Cell Death Differ. 2003 Sep;10(9):1025-31
references.pmid: 12934077
references.citation: Science. 2001 Dec 7;294(5549):2166-70
references.pmid: 11739957
references.citation: Biochem Biophys Res Commun. 2000 Oct 22;277(2):361-7
references.pmid: 11032731
references.citation: J Clin Endocrinol Metab. 2007 Nov;92(11):4332-9
references.pmid: 17711920
references.citation: J Clin Endocrinol Metab. 2011 Mar;96(3):632-42
references.pmid: 21193542
references.citation: Mol Endocrinol. 2010 Apr;24(4):813-21
references.pmid: 20172962
references.citation: Nat Rev Mol Cell Biol. 2011 Sep 28;12(11):722-34
references.pmid: 21952300
references.citation: J Clin Invest. 1989 Nov;84(5):1663-70
references.pmid: 2681273
references.citation: J Endocrinol. 2008 May;197(2):297-307
references.pmid: 18434359
references.citation: Adv Enzyme Regul. 1987;26:355-82
references.pmid: 2960133
references.citation: Endocrinology. 2003 Jan;144(1):253-9
references.pmid: 12488352
references.citation: Steroids. 2011 Dec 20;76(14):1546-53
references.pmid: 21945397
references.citation: Clin Chim Acta. 1982 Dec 9;126(2):135-41
references.pmid: 6217923
references.citation: Cell Signal. 2001 Mar;13(3):169-75
references.pmid: 11282455
references.citation: Nutr Rev. 1999 Oct;57(10):324-6
references.pmid: 10575910
references.citation: Endocrinology. 2005 Jun;146(6):2539-43
references.pmid: 15774558
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14924-9
references.pmid: 9405715
references.citation: Int J Obes. 1986;10(3):193-204
references.pmid: 2944850
references.citation: Eur J Endocrinol. 2004 Jul;151(1):1-14
references.pmid: 15248817
references.citation: Diabetes. 1982 Sep;31(9):830-3
references.pmid: 6219024
references.citation: Am J Physiol Endocrinol Metab. 2012 Mar 15;302(6):E694-704
references.pmid: 22234368
references.citation: J Clin Endocrinol Metab. 2009 Dec;94(12):4645-54
references.pmid: 19837912
references.citation: Diabetes. 2004 Jan;53(1):41-52
references.pmid: 14693696
references.citation: Diabetes Care. 2010 Jul;33(7):1516-22
references.pmid: 20413513
references.citation: Am J Physiol Endocrinol Metab. 2005 May;288(5):E957-64
references.pmid: 15613680
references.citation: Endocrinology. 1999 Jul;140(7):3188-96
references.pmid: 10385414
references.citation: Diabetes. 2009 Jan;58(1):14-5
references.pmid: 19114723
references.citation: Mol Cell Endocrinol. 2010 May 14;320(1-2):51-7
references.pmid: 20176080
references.citation: Int J Obes Relat Metab Disord. 1997 Nov;21(11):1058-64
references.pmid: 9368831
references.citation: Exp Cell Res. 1991 Oct;196(2):270-8
references.pmid: 1893938
references.citation: Diabetes. 2000 Oct;49(10):1700-8
references.pmid: 11016454